Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,287 across all filing types
Latest filing 2026-01-05 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司第十一届董事会第十次（临时）会议决议公告
Capital/Financing Update Classification · 95% confidence The document is an announcement of the resolutions passed at a board meeting regarding the proposal to issue non-public exchangeable corporate bonds. It details the board's approval of the bond issuance plan, including terms, conditions, and authorization for further actions. The document is a formal announcement of board decisions and plans for financing activities, not the actual issuance or detailed financial report. It does not contain financial statements or detailed financial analysis but focuses on the board's resolutions related to capital raising. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 4500 characters, which is consistent with an announcement rather than a full report. Hence, the classification is CAP with high confidence.
2026-01-05 Chinese
辽宁成大股份有限公司2026年第一次临时股东会会议文件
Proxy Solicitation & Information Statement Classification · 82% confidence The document is the full agenda and detailed proposals for the company’s 2026 first extraordinary shareholders meeting (临时股东会), including items to be voted on and explanatory resolutions. It is not an annual report, earnings release, or certification letter, nor is it merely a short announcement. These materials are sent to shareholders to provide information ahead of and to solicit votes for the meeting. Therefore, it fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-01-05 Chinese
辽宁成大股份有限公司关于召开2026年第一次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2026 first extraordinary general meeting of shareholders (临时股东会) for 辽宁成大股份有限公司. It details the meeting date, voting methods, agenda items for shareholder approval, and procedural instructions for attendance and voting. It does not contain financial statements or detailed financial analysis. It is an announcement of a shareholder meeting and the related voting matters, not the meeting materials or results themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and agenda rather than solicitation materials or voting results, it is best classified as a Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it is not merely announcing a report publication. Hence, the best fit is PSI.
2026-01-05 Chinese
辽宁成大股份有限公司第十一届董事会第九次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 辽宁成大股份有限公司. It includes voting results on specific proposals and references other announcements for details. The content focuses on board decisions rather than detailed financial data or full reports. The document length is short (685 characters), and it serves as a notice of board meeting resolutions rather than a full management or financial report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board.
2025-12-31 Chinese
辽宁成大股份有限公司关于2026年度开展商品期货业务和外汇衍生品业务的可行性分析报告
Management Reports Classification · 95% confidence The document is a detailed feasibility analysis report regarding the company's plan to engage in commodity futures and foreign exchange derivatives business for the year 2026. It includes descriptions of business purposes, types of transactions, risk analysis, risk control measures, accounting principles, and a conclusion on feasibility. There are no indications that this is an announcement of a report publication or a brief summary. It is not a financial statement or earnings release, nor is it a regulatory filing or certification. The content is focused on management's detailed explanation and analysis of business strategy and risk management related to financial derivatives, which aligns with a Management Report (MDA). The document length is 3762 characters, which is relatively short but contains substantive content and analysis rather than just an announcement or summary. Therefore, the best fit is Management Reports (MDA).
2025-12-31 Chinese
辽宁成大股份有限公司关于全资子公司所持股权内部划转的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Liaoning Chengda Co., Ltd. regarding an internal transfer of equity held by its wholly-owned subsidiary. It details the transfer of 100% equity of a subsidiary from one wholly-owned subsidiary to the parent company. The document includes background, basic information about the parties involved, the transfer plan, and the impact on the company. It explicitly states that this is an internal equity transfer, not a major asset restructuring or related party transaction, and does not affect consolidated financial statements materially. The document is relatively short (2015 characters) and is a formal announcement of a corporate action rather than a financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-12-31 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.